Original Research
Accepted on 13 Feb 2026
Hemophagocytic Lymphohistiocytosis Directly Triggered by Peginterferon Alfa-2b in a Patient with Chronic Hepatitis B
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 293 views
Type at least 3 characters
1,320 articles
articles
Original Research
Accepted on 13 Feb 2026
Targeting neuroinflammation: itaconate and mesaconate as therapeutic strategies against H7N7 influenza-associated CNS damage
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
Case Report
Published on 13 Feb 2026
Case Report: Tezepelumab as rescue therapy in near-fatal asthma requiring extracorporeal membrane oxygenation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1722963
- 382 views
Original Research
Published on 13 Feb 2026
The role of soluble toll-like receptor-2 and 4 in children with pneumonia: a combined analysis of saliva and serum samples
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1657027
- 410 views
Original Research
Accepted on 12 Feb 2026
Exploring alternative cytokines as potential biomarkers for Mycobacterium bovis infection in cattle
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
Original Research
Accepted on 12 Feb 2026
Principal Component Analysis of Cytokine Signature in COVID-19 and Long COVID
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 251 views
Original Research
Published on 12 Feb 2026
Efficacy of Interleukin 8 (IL-8) in the detection of urinary tract infection
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1684579
- 355 views
Original Research
Published on 12 Feb 2026
Cytokine profiles and laboratory parameters as indicators to distinguish children with PFAPA and bacterial infection
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1683221
- 252 views
Review
Published on 12 Feb 2026
Targeting cellular source-specific CXCL9 signaling for immunotherapy in oral squamous cell carcinoma
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1768606
- 282 views
Original Research
Accepted on 11 Feb 2026
The cytokine-signature in Multiple Sclerosis. A study during SARS-Cov-2 pandemic
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 131 views
Review
Published on 11 Feb 2026
Cytokines and related signaling pathways in traumatic brain injury
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1738589
- 452 views
Original Research
Published on 11 Feb 2026
Integrative analysis of DNA methylation and inflammatory protein biomarkers in hypertension
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1671540
- 413 views
Mini Review
Published on 09 Feb 2026
IL-35, IL-37, and IL-38 in acute pancreatitis: proposed immunopathogenic mechanisms and therapeutic potential
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1728737
- 330 views
Mini Review
Accepted on 06 Feb 2026
Interleukins in Community-Acquired Pneumonia: From Biomarkers to Precision Medicine
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 266 views
Original Research
Accepted on 06 Feb 2026
PBMC Transcriptomic Signatures Reflect Immune Dynamics and Disease Activity in Psoriatic Arthritis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 111 views
Original Research
Published on 06 Feb 2026
Association of SARS-CoV-2 infection with long-lasting increase in circulating IL-32 levels
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1739258
- 1,335 views
Original Research
Published on 06 Feb 2026
Oncostatin M upregulates CD73 via the MAPK pathway in keratinocytes to promote an adenosine-dependent anti-inflammatory response in psoriasis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1698290
- 562 views
Original Research
Published on 06 Feb 2026
Glycosaminoglycan binding to soluble CX3CL1 impacts monocyte migration in vitro
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1747705
- 944 views
Mini Review
Published on 04 Feb 2026
CX3CL1/CX3CR1 axis in liver disease: context-dependent roles and balance
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1763348
- 419 views
Original Research
Published on 04 Feb 2026
Persistent neutrophil activation despite count normalization suggests immune dysregulation in exertional heat stroke
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1718617
- 596 views
Review
Accepted on 03 Feb 2026
Health Risk Analysis of Micro-and Nanoplastic Exposure via the Microbiota-Gut-Brain Axis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 132 views
Original Research
Published on 03 Feb 2026
Homoeriodictyol, targeting the bitter taste receptor TAS2R14, lowers the secretion of pro-inflammatory chemokines upon treatment with SARS-CoV-2 peptide pools in human peripheral blood mononuclear cells
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2026.1771794
- 634 views
Original Research
Accepted on 02 Feb 2026
The Diagnostic Accuracy of CC Chemokine Ligand 23 for Kawasaki Disease
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
Review
Accepted on 02 Feb 2026
Unraveling Fibrinogen-like Protein 1's Role in Immune Regulation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology